About Bexsero

WHAT YOU NEED TO KNOW ABOUT BEXSERO

The first meningitis B* vaccine indicated as early as 2 months through 25 years of age.

BEXSERO helps provide protection against invasive meningococcal disease (IMD) caused by bacteria Neisseria meningitidis group B strains (meningitis B*).

IS BEXSERO PART OF A ROUTINE VACCINATION SCHEDULE?

BEXSERO or vaccination against meningitis B* is not part of your routine vaccination schedule.

Help protect yourself against
meningitis B*

DID YOU KNOW THIS ABOUT BEXSERO?

It is part of 8 immunization programs in different countries including UK, Ireland, Italy, South Australia, Andorra, San Marino, Spain, and Lithuania.

+76 million doses distributed worldwide from 2015 to 2021*^†

Talk to your doctor about BEXSERO

* Invasive meningococcal disease caused by Neisseria meningitidis group B strains.

† 30,696,000 doses distributed worldwide from March 2015 to August 2018.

Dosing

Recommended vaccination schedule:

Child, adolescent, or adult, 2 through 25 years of age

PRIMARY IMMUNIZATION

2 primary doses – Each dose is 0.5 mL

At least 1 month apart

1 booster dose – (0.5 mL)

May be considered in individuals at continuous risk of exposure to meningococcal disease.

BEXSERO dosing schedule can be completed during your summer break.

To download this dosing schedule, click on the button below.

Download This Schedule

Make sure that you get all prescribed doses. This allows you to get the full benefits of BEXSERO.

Potential side effects

Like all vaccines, BEXSERO may cause side effects, although not everybody gets them.

When BEXSERO is administered, very common side effects* (affecting more than 1 in 10 people) you may experience at the site of injection include:

pain/tenderness
redness of the skin
swelling of the skin
hardness of the skin

* Reported in all age groups 2 months through 25 years of age.

Side effects may occur after receiving this vaccine. Click to view possible side effects:

Individuals 11 years of age or older

Reporting a side effect (or adverse event)

If you need to report an adverse event, please call 1-800-387-7374.

Please note: Your healthcare professional is the best source of information regarding your health. You are advised to discuss the advantages and disadvantages of BEXSERO with your healthcare professional before receiving the vaccine.

For complete instructions, see the Consumer Information leaflet that comes with your BEXSERO prescription.

BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 25 years of age. BEXSERO is not expected to protect against all circulating meningococcal serogroup B strains and does not offer protection against strains A, C, Y, and W-135. As with any vaccine, BEXSERO may not fully protect all of those who are vaccinated. BEXSERO does not treat or reduce the consequences of meningococcal disease, including meningitis, sepsis, and death. The very common side effects (may affect more than 1 in 10 people) after vaccination with BEXSERO (reported in all age groups) were pain/tenderness at the injection site, redness at the injection site, swelling of the skin at the injection site, and hardness of the skin at the injection site. In infants and children (up to 10 years of age), fever can occur more frequently when BEXSERO is given at the same time as routine infant vaccines. Allergic reactions may also occur. Ask your healthcare professional if BEXSERO is right for you. Full product information can be found at http://gsk.ca/bexsero/en. To report an adverse event, please call 1-800-387-7374.

For information about how GSK uses, shares, and protects personal information, including information collected online, please read GSK's Privacy Statement.

Please note: This site does not provide medical advice. The contents of this site are for information purposes only and are not in any way intended to replace or substitute the advice of your healthcare professional. Your healthcare professional is the best source of information regarding your health. This digital channel is not intended as a means for reporting an adverse event (side effect) or complaint for any GlaxoSmithKline product. To report an adverse event or product complaint, please call 1-800-387-7374. This site is intended for use by Canadian residents only.

10287
07/23

How are you tracking your family’s vaccination records? Download a digital tool here